MarketPulse

Buy rating

2 articles
The Motley FoolThe Motley Fool··Parkev Tatevosian, Cfa

Analyst Issues First-Ever Buy Rating on Archer Aviation, Signals Turning Point for eVTOL Sector

Motley Fool upgrades Archer Aviation to buy for first time, citing significant upside but emphasizing this high-risk investment suits only aggressive investors.
ACHRACHR.WSeVTOLstock upgrade
BenzingaBenzinga··Vandana Singh

BofA Initiates Buy on Ligand Pharma, Sees $244 Upside in Royalty Model

Bank of America initiates Buy coverage on Ligand Pharmaceuticals with $244 price target, citing differentiated royalty model and strong Q4 results beating earnings expectations.
LGNDportfolio diversificationearnings beat